✦ LIBER ✦

Altered glucose metabolism in Alzheimer's disease

✍ Scribed by Neil R. Sims

Publisher: John Wiley and Sons
Year: 1990
Tongue: English
Weight: 245 KB
Volume: 27
Category: Article
ISSN: 0364-5134
DOI: 10.1002/ana.410270621

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Altered glucose metabolism in microvesse

Altered glucose metabolism in microvessels from patients with Alzheimer's disease

✍ Sami I. Harik; Joseph C. LaManna PhD 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 138 KB 👁 1 views

Altered glucose metabolism in microvesse

Altered glucose metabolism in microvessels from patients with Alzheimer's disease

✍ Dr David L. Marcus; Mony J. de Leon; Jeffrey Goldman; Jean Logan; David R. Chris 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 430 KB 👁 2 views

Altered cell-matrix associated ADAM prot

Altered cell-matrix associated ADAM proteins in Alzheimer disease

✍ Jennifer L. Gerst; Arun K. Raina; Ibrahim Pirim; Andrew McShea; Peggy L.R. Harri 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 416 KB 👁 1 views

Alterations in cell-matrix 'contact' are often related to a disruption of cell cycle regulation and, as such, occur variously in neoplasia. Given the recent findings showing cell cycle alterations in Alzheimer disease, we undertook a study of ADAM-1 and 2 (A Disintegrin And Metalloprotease), develop

ALZHEIMER'S DISEASE IN POLAND

✍ B. SZCZEPANOWSKA 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB 👁 2 views

Reduced glucose transporter concentratio

Reduced glucose transporter concentrations in brains of patients with Alzheimer's disease

✍ Ian A. Simpson; Peter Davies 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 242 KB 👁 2 views

Altered plasma antioxidant status in sub

Altered plasma antioxidant status in subjects with Alzheimer's disease and vascular dementia

✍ Alan J. Sinclair; Antony J. Bayer; Jo Johnston; Catriona Warner; Simon R. J. Max 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 87 KB 👁 2 views

Objectives. Oxygen-free radicals and lipid hydroperoxides may have an aetiological role in the development of lesions in the central nervous system in patients with Alzheimer's disease and in those with vascular dementia. This study aimed to make a cross-sectional comparison of blood markers of oxid